12.05.2008 11:00:00
|
LabCorp is Scheduled to Present at the Bank of America 2008 Health Care Conference
Laboratory Corporation of America®
Holdings (LabCorp®)
(NYSE: LH) today announced that David P. King, Chief Executive Officer
and William B. (Brad) Hayes, Executive Vice President and Chief
Financial Officer, are scheduled to speak at the Bank of America 2008
Health Care Conference in Las Vegas, NV. LabCorp’s
presentation is planned for Wednesday, May 14, 2008 at 9:20 a.m.
(Pacific Time).
A live audio webcast of the presentation will be available via the
Company Web site at www.labcorp.com
and archived for replay.
About LabCorp
Laboratory Corporation of America®
Holdings, a S&P 500 company, is a pioneer in commercializing new
diagnostic technologies and the first in its industry to embrace genomic
testing. With annual revenues of $4.1 billion in 2007, over 26,000
employees nationwide, and more than 220,000 clients, LabCorp offers
clinical assays ranging from routine blood analyses to HIV and genomic
testing. LabCorp combines its expertise in innovative clinical testing
technology with its Centers of Excellence: The Center for Molecular
Biology and Pathology, National Genetics Institute, Inc., ViroMed
Laboratories, Inc., The Center for Esoteric Testing, DIANON Systems,
Inc., US LABS, and Esoterix and its Colorado Coagulation, Endocrine
Sciences, and Cytometry Associates laboratories. LabCorp conducts
clinical trial testing through its Esoterix Clinical Trials Services
division. LabCorp clients include physicians, government agencies,
managed care organizations, hospitals, clinical labs, and pharmaceutical
companies. To learn more about our organization, visit our Web site at: www.labcorp.com.
Each of the above forward-looking statements is subject to change
based on various important factors, including without limitation,
competitive actions in the marketplace and adverse actions of
governmental and other third-party payors. Actual results could
differ materially from those suggested by these forward-looking
statements. Further information on potential factors that could affect
LabCorp’s financial results is included in the
Company’s Form 10-K for the year ended
December 31, 2007, and subsequent SEC filings.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Laboratory Corp. of America Holdingsmehr Nachrichten
Keine Nachrichten verfügbar. |